succinic acid has been researched along with Atherosclerosis in 4 studies
Succinic Acid: A water-soluble, colorless crystal with an acid taste that is used as a chemical intermediate, in medicine, the manufacture of lacquers, and to make perfume esters. It is also used in foods as a sequestrant, buffer, and a neutralizing agent. (Hawley's Condensed Chemical Dictionary, 12th ed, p1099; McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed, p1851)
succinic acid : An alpha,omega-dicarboxylic acid resulting from the formal oxidation of each of the terminal methyl groups of butane to the corresponding carboxy group. It is an intermediate metabolite in the citric acid cycle.
Atherosclerosis: A thickening and loss of elasticity of the walls of ARTERIES that occurs with formation of ATHEROSCLEROTIC PLAQUES within the ARTERIAL INTIMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| " It is well known that Puerarin and Tanshinone IIA (Pue-Tan) can significantly reduce interleukin-1β (IL-1β) levels and delay the atherosclerosis (AS) process clinically in China." | 8.31 | Puerarin-Tanshinone IIA Suppresses atherosclerosis inflammatory plaque via targeting succinate/HIF-1α/IL-1β axis. ( Cui, Y; Du, X; Gao, M; Hou, Y; Li, Z; Tian, Z; Wang, J; Xu, J, 2023) |
| " It is well known that Puerarin and Tanshinone IIA (Pue-Tan) can significantly reduce interleukin-1β (IL-1β) levels and delay the atherosclerosis (AS) process clinically in China." | 4.31 | Puerarin-Tanshinone IIA Suppresses atherosclerosis inflammatory plaque via targeting succinate/HIF-1α/IL-1β axis. ( Cui, Y; Du, X; Gao, M; Hou, Y; Li, Z; Tian, Z; Wang, J; Xu, J, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, S | 1 |
| Liang, Y | 1 |
| Li, L | 1 |
| Chen, Y | 1 |
| Wu, P | 1 |
| Wei, D | 1 |
| Kong, XL | 1 |
| Lyu, Q | 1 |
| Zhang, YQ | 1 |
| Kang, DF | 1 |
| Li, C | 1 |
| Zhang, L | 1 |
| Gao, ZC | 1 |
| Liu, XX | 1 |
| Wu, JB | 1 |
| Li, YL | 1 |
| Xu, J | 1 |
| Tian, Z | 1 |
| Li, Z | 1 |
| Du, X | 1 |
| Cui, Y | 1 |
| Wang, J | 1 |
| Gao, M | 1 |
| Hou, Y | 1 |
| Gupte, AA | 1 |
| Minze, LJ | 1 |
| Reyes, M | 1 |
| Ren, Y | 1 |
| Wang, X | 1 |
| Brunner, G | 1 |
| Ghosn, M | 1 |
| Cordero-Reyes, AM | 1 |
| Ding, K | 1 |
| Pratico, D | 1 |
| Morrisett, J | 1 |
| Shi, ZZ | 1 |
| Hamilton, DJ | 1 |
| Lyon, CJ | 1 |
| Hsueh, WA | 1 |
1 review available for succinic acid and Atherosclerosis
| Article | Year |
|---|---|
Succinate: A Novel Mediator to Promote Atherosclerotic Lesion Progression.
Topics: Animals; Atherosclerosis; Disease Progression; Endothelial Cells; Humans; Macrophages; Mice; Models, | 2022 |
3 other studies available for succinic acid and Atherosclerosis
| Article | Year |
|---|---|
Effect of astragaloside IV and salvianolic acid B on antioxidant stress and vascular endothelial protection in the treatment of atherosclerosis based on metabonomics.
Topics: Antioxidants; Atherosclerosis; Benzofurans; Endothelial Cells; Humans; Methionine; Saponins; Succini | 2022 |
Puerarin-Tanshinone IIA Suppresses atherosclerosis inflammatory plaque via targeting succinate/HIF-1α/IL-1β axis.
Topics: Animals; Atherosclerosis; Hypoxia; Interleukin-1beta; Mice; Molecular Docking Simulation; Plaque, At | 2023 |
High-fat feeding-induced hyperinsulinemia increases cardiac glucose uptake and mitochondrial function despite peripheral insulin resistance.
Topics: Age Factors; Animals; Atherosclerosis; Blotting, Western; Diet, High-Fat; Fatty Liver; Glucose; Glut | 2013 |